HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014–2019

References

• NCAIDS N, China CDC. Update on the AIDS/STD epidemic in China in August, 2018. Chin J AIDS STD. 2018;24:965. doi:10.13419/j.cnki.aids.2018.10.01
   Google Scholar
• Boyd AT, Oboho I, Paulin H, et al. Addressing advanced HIV disease and mortality in global HIV programming. AIDS Res Ther. 1999;17(1):40. doi:10.1186/s12981-020-00296-x
   Web of Science ®Google Scholar
• Hingankar NK, Thorat SR, Deshpande A, et al. Initial virologic response and HIV drug resistance among HIV-infected individuals initiating firstline antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. Clin Infect Dis. 2012;54(suppl_4):S348–54. doi:10.1093/cid/cis00522544202
   PubMed Web of Science ®Google Scholar
• Beyrer C, Abdool Karim Q. The changing epidemiology of HIV in 2013. Curr Opin HIV AIDS. 2013;8:306–310. doi:10.1097/COH.0b013e328361f53a23743721
   PubMed Web of Science ®Google Scholar
• Li Z, Liao L, Feng Y, et al. Trends of HIV subtypes and phylogenetic dynamics among young men who have sex with men in China, 2009–2014. Sci Rep. 2015;5(1):16708. doi:10.1038/srep1670826577039
   PubMed Web of Science ®Google Scholar
• Li Y, Lin P, Wang Y, et al. HIV/AIDS surveillance in Guangdong Province, 2000–2013. South Chin J Prev Med. 2015;41:101–106. doi:10.13217/j.scjpm.2015.0101
   Google Scholar
• Zhang J, Guo Z, Pan X, et al. Highlighting the crucial role of Hangzhou in HIV-1 transmission among men who have sex with men in Zhejiang, China. Sci Rep. 2017;7(1):13892. doi:10.1038/s41598-017-14108-229066776
   PubMed Web of Science ®Google Scholar
• Struck D, Lawyer G, Ternes AM, et al. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification. Nucleic Acids Res. 2014;42(18):e144. doi:10.1093/nar/gku73925120265
   PubMed Web of Science ®Google Scholar
• Guindon S, Dufayard JF, Lefort V, et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59(3):307–321. doi:10.1093/sysbio/syq01020525638
   PubMed Web of Science ®Google Scholar
• Anisimova M, Gascuel O, Sullivan J. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst Biol. 2006;55(4):539–552. doi:10.1080/1063515060075545316785212
   PubMed Web of Science ®Google Scholar
• Tang MW, Liu TF, Shafer RW. The HIVdb system for HIV-1 genotypic resistance interpretation. Intervirology. 2012;55(2):98–101. doi:10.1159/00033199822286876
   PubMed Web of Science ®Google Scholar
• Stanford University HIV drug resistance database. Major HIV-1 Drug Resistance Mutations; 2020. Available from: https://cms.hivdb.org/prod/downloads/resistance-mutation-handout/resistance-mutation-handout.pdf. Accessed 722, 2021.
   Google Scholar
• Wertheim JO, Kosakovsky Pond SL, Forgione LA, et al. Social and genetic networks of HIV-1 transmission in New York City. PLoS Pathog. 2017;13(1):e1006000. doi:10.1371/journal.ppat.100600028068413
   PubMed Web of Science ®Google Scholar
• Hassan AS, Pybus OG, Sanders EJ, et al. Defining HIV-1 transmission clusters based on sequence data. AIDS. 2017;31(9):1211–1222. doi:10.1097/QAD.000000000000147028353537
   PubMed Web of Science ®Google Scholar
• Yu G, Li Y, Huang X, et al. Genetic diversity and drug resistance of HIV-1 CRF55_01B in Guangdong, China. Curr HIV Res. 2020;18(3):210–218. doi:10.2174/1570162X1866620041514065232294040
   PubMed Web of Science ®Google Scholar
• Han X, An M, Zhang M, et al. Identification of 3 distinct HIV-1 founding strains responsible for expanding epidemic among men who have sex with men in 9 Chinese cities. J Acquir Immune Defic Syndr. 2013;64(1):16–24. doi:10.1097/QAI.0b013e318293221023542640
   PubMed Web of Science ®Google Scholar
• Han X, An M, Zhang W, et al. Genome sequences of a novel HIV-1 circulating recombinant form, CRF55_01B, identified in China. Genome Announc. 2013;1:e00050–12. doi:10.1128/genomeA.00050-1223405298
   PubMedGoogle Scholar
• Zhao J, Cai W, Zheng C, et al. Origin and outbreak of HIV-1 CRF55_01B among MSM in Shenzhen, China. J Acquir Immune Defic Syndr. 2014;66(3):e65–7. doi:10.1097/QAI.000000000000014424662297
   PubMed Web of Science ®Google Scholar
• Zhou PP, Yu G, Kuang YQ, et al. Rapid and complicated HIV genotype expansion among high-risk groups in Guangdong Province, China. BMC Infect Dis. 2019;19(1):185. doi:10.1186/s12879-019-3788-730795762
   PubMed Web of Science ®Google Scholar
• Lan Y, He X, Li L, et al. Complicated genotypes circulating among treatment naïve HIV-1 patients in Guangzhou, China. Infect Genet Evol. 2021;87:104673. doi:10.1016/j.meegid.2020.10467333309773
   PubMed Web of Science ®Google Scholar
• Ruan WQ, Liu JF, Zhang M, et al. Genotypic drug resistance of HIV-infected MSM who failed in antiviral therapy in Yunnan Province. Prev Med. 2020;3(2):987–991+995. doi:10.19485/j.cnki.issn2096-5087.2020.10.004
   Google Scholar
• Yuan D, Du Z, Zhou J, et al. HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017. Medicine (Baltimore). 2019;98(43):e17585. doi:10.1097/MD.000000000001758531651864
   PubMed Web of Science ®Google Scholar
• Zou X, He J, Zheng J, et al. Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China. Virol J. 2020;17(1):38. doi:10.1186/s12985-020-01311-332183889
   PubMed Web of Science ®Google Scholar
• Vannappagari V, Ragone L, Henegar C, et al. Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review. Antivir Ther. 2019;24(6):393–404. doi:10.3851/IMP333131503008
   PubMed Web of Science ®Google Scholar
• Xu HT, Martinez-Cajas JL, Ntemgwa ML, et al. Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance. Retrovirology. 2009;6(1):14. doi:10.1186/1742-4690-6-1419210791
   PubMed Web of Science ®Google Scholar
• Rhee SY, Gonzales MJ, Kantor R, et al. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 2003;31(1):298–303. doi:10.1093/nar/gkg10012520007
   PubMed Web of Science ®Google Scholar
• Melikian GL, Rhee SY, Varghese V, et al. Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing. J Antimicrob Chemother. 2014;69(1):12–20. doi:10.1093/jac/dkt31623934770
   PubMed Web of Science ®Google Scholar
• Sno R, Labadie-Bracho MY, Grünberg MG, et al. First assessment of acquired HIV-1 drug resistance and mutation patterns in suriname. AIDS Res Hum Retroviruses. 2021;37(7):557–565. doi:10.1089/AID.2020.019433287618
   PubMed Web of Science ®Google Scholar
• Omooja J, Nannyonjo M, Sanyu G, et al. Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda. J Antimicrob Chemother. 2019;74(10):3021–3029. doi:10.1093/jac/dkz26131257432
   PubMed Web of Science ®Google Scholar
• Li T, Qian F, Yuan T, et al. Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China. Virol Sin. 2017;32(4):271–279. doi:10.1007/s12250-017-4002-y28795354
   PubMed Web of Science ®Google Scholar
• Zuo L, Liu K, Liu H, et al. Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001–2017). EClinicalMedicine. 2020;18:100238. doi:10.1016/j.eclinm.2019.10023831922125
   PubMedGoogle Scholar
• McCluskey SM, Siedner MJ, Marconi VC. Management of virologic failure and HIV drug resistance. Infect Dis Clin North Am. 2019;33(3):707–742. doi:10.1016/j.idc.2019.05.00431255384
   PubMed Web of Science ®Google Scholar
• Sui H, Gui T, Jia L, et al. Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a Comprehensive Study. PLoS One. 2014;9(3):e91803. doi:10.1371/journal.pone.009180324663120
   PubMed Web of Science ®Google Scholar
• Zhang D, Wu J, Zhang Y, et al. Genetic characterization of HIV-1 epidemic in Anhui Province, China. Virol J. 2020;17(1):17. doi:10.1186/s12985-020-1281-y32014042
   PubMed Web of Science ®Google Scholar